Behavioral toxicology in the 21st century: Challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the Neurobehavioral Teratology Society, June, 2009

Neurotoxicology and Teratology

Volumn 32, Issue 3, 2010, Pages 313-328

  Bushnell, Philip J ^a   Kavlock, Robert J ^b   Crofton, Kevin M ^a   Weiss, Bernard ^c   Rice, Deborah C ^d  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d Maine Department of Health and Human Services   (United States)

Author keywords

Alternative methods; Behavioral toxicology; Narcosis pathway; Phthalates; Risk assessment; Thyroid hormone pathway; Toxicity pathway; Toxicity testing

Indexed keywords

ANESTHETIC AGENT; CHLORPYRIFOS; PHOSALONE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIBUTYL ESTER; SOLVENT; THYROID HORMONE; TOLUENE; VINCLOZOLIN;

ARTICLE; BEHAVIORAL SCIENCE; CARCINOGENICITY; DANGEROUS GOODS; DEVELOPMENTAL DISORDER; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HORMONE METABOLISM; HUMAN; MEDICAL SOCIETY; MUTAGENICITY; NEUROTOXICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PUERTO RICO; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS;

ANESTHETICS; ANIMALS; BEHAVIORAL SCIENCES; HUMANS; NERVOUS SYSTEM; ORGANOPHOSPHORUS COMPOUNDS; SOLVENTS; TERATOLOGY; TOXICITY TESTS;

ANIMALIA; MAMMALIA;

EID: 77951205036     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2010.02.002     Document Type: Article

References (91)

1. Andrade A.J., Grande S.W., Talsness C.E., Grote K., Chahoud I. A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate (DEHP): non-monotonic dose-response and low dose effects on rat brain aromatase activity. Toxicology 2006, 227:185-192.
2. Aschner M., Crofton K.M., Levin E.D. Introduction to the special issue on emerging high throughput and complementary model screens for neurotoxicology. Neurotoxicol. Teratol. 2010, 32:1-3.
3. Bale A.S., Meacham C.A., Benignus V.A., Bushnell P.J., Shafer T.J. Volatile organic compounds inhibit human and rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. Toxicol. Appl. Pharmacol. 2005, 205:77-88.
4. Benignus V.A., Boyes W.K., Bushnell P.J. A dosimetric analysis of behavioral effects of acute toluene exposure in rats and humans. Toxicol. Sci. 1998, 43:186-195.
5. Benignus V.A., Bushnell P.J., Boyes W.K. Toward cost-benefit analysis of acute behavioral effects of toluene in humans. Risk Anal. 2005, 25:447-456.
6. Benignus V.A., Geller A.M., Boyes W.K., Bushnell P.J. Human neurobehavioral effects of long-term exposure to styrene: a meta-analysis. Environ. Health Perspect. 2005, 113:532-538.
7. Benignus V.A., Coleman T., Eklund C., Kenyon E.M. A general physiological and toxicokinetic (GPAT) model for simulating complex toluene exposure scenarios in humans. Toxicol. Mech. Meth. 2006, 16:27-33.
8. Benignus V.A., Boyes W.K., Kenyon E.M., Bushnell P.J. Quantitative comparisons of the acute neurotoxicity of toluene in rats and humans. Toxicol. Sci. 2007, 100:146-155.
9. Benignus V.A., Bushnell P.J., Boyes W.K., Eklund C., Kenyon E.M. Neurobehavioral effects of acute exposure to four solvents: meta-analyses. Toxicol. Sci. 2009, 109:296-305.
10. Boobis A.R., Doe J.E., Heinrich-Hirsch B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 2008, 38:87-96.
11. Bornehag C.G., Sundell J., Weschler C.J., Sigsgaard T., Lundgren B., Hasselgren M., Hagerhed-Engman L. The association between asthma and allergic symptoms in children and phthalates in house dust: a nested case-control study. Environ. Health Perspect. 2004, 112:1393-1397.
12. Bowen S.E., Batis J.C., Paez-Martinez N., Cruz S.L. The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol. Teratol. 2006, 28:636-647.
13. Boyages S.C., Halpern J.P. Endemic cretinism: toward a unifying hypothesis. Thyroid 1993, 3:59-69.
14. Boyes W.K., Bercegeay M., Krantz Q.T., Kenyon E.M., Bale A.S., Shafer T.J., Bushnell P.J., Benignus V.A. Acute toluene exposure and rat visual function in proportion to momentary brain concentration. Toxicol. Sci. 2007, 99:572-581.
15. Brent G.A. Tissue-specific actions of thyroid hormone: insights from animal models. Rev. Endocr. Metab. Disord. 2000, 1:27-33.
16. Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid 1998, 8:827-856.
17. Bushnell P.J., Shafer T.J., Bale A.S., Boyes W.K. Development and applications of an exposure-dose-response model for organic solvents. Environ. Toxicol. Pharmacol. 2005, 19:607-614.
18. Bushnell P.J., Oshiro W.M., Samsam T.E., Benignus V.A., Krantz Q.T., Kenyon E.M. A dosimetric analysis of the acute behavioral effects of inhaled toluene in rats. Toxicol. Sci. 2007, 99:181-189.
19. Campagna J.A., Miller K.W., Forman S.A. Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med. 2003, 348:2110-2124.
20. Capen C.C. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol. Pathol. 1997, 25:39-48.
21. Clewell H.J., Gearhart J.M., Gentry P.R., Covington T.R., VanLandingham C.B., Crump K.S., Shipp A.M. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal. 1999, 19:547-558.
22. T.Committee on Toxicity, N.R.C.Assessment of Environmental Agents Toxicity Testing in the 21st Century: a Vision and a Strategy 2007, National Academy Press, Washington, DC.
23. Crofton K.M. Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats. Risk Anal. 2004, 24:1665-1671.
24. Crofton K.M. Thyroid disrupting chemicals: mechanisms and mixtures. Int. J. Androl. 2008, 31:209-223.
25. Crofton K.M., Zoeller R.T. Mode of action: neurotoxicity induced by thyroid hormone disruption during development - hearing loss resulting from exposure to PHAHs. Crit. Rev. Toxicol. 2005, 35:757-769.
26. Cruz S.L., Mirshahi T., Thomas B., Balster R.L., Woodward J.J. Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 1998, 286:334-340.
27. DeVito M., Biegel L., Brouwer A., Brown S., Brucker-Davis F., Cheek A.O., Christensen R., Colborn T., Cooke P., Crissman J., et al. Screening methods for thyroid hormone disruptors. Environ. Health Perspect. 1999, 107:407-415.
28. Dix D.J., Houck K.A., Martin M.T., Richard A.M., Setzer R.W., Kavlock R.J. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol. Sci. 2007, 95:5-12.
29. Eger E.I., Tang M., Liao M., Laster M.J., Solt K., Flood P., Jenkins A., Raines D., Hendrickx J.F., Shafer S.L., et al. Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats. Anesthes. Analg. 2008, 107:479-485.
30. EPA ORD'sComputational Toxicology Implementation Plan (FY 2006-2008) 2006.
31. EPA The U.S. Environmental Protection Agency's strategic plan for evaluating the toxicity of chemicals 2009.
32. Field E.A., Price C.J., Sleet R.B., George J.D., Marr M.C., Myers C.B., Schwetz B.A., Morrissey R.E. Developmental toxicity evaluation of diethyl and dimethyl phthalate in rats. Teratology 1993, 48:33-44.
33. Fini J.B., Le Mevel S., Turque N., Palmier K., Zalko D., Cravedi J.P., Demeneix B.A. An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. Environ. Sci. Technol. 2007, 41:5908-5914.
34. Ganning A.E., Brunk U., Dallner G. Phthalate esters and their effect on the liver. Hepatology 1984, 4:541-547.
35. Gorski R.A. Sexual differentiation of the brain: a model for drug-induced alterations of the reproductive system. Environ. Health Perspect. 1986, 70:163-175.
36. Gray D.G. A physiologically based pharmacokinetic model for methyl mercury in the pregnant rat and fetus. Toxicol. Appl. Pharmacol. 1995, 132:91-102.
37. Gray T.J., Butterworth K.R. Testicular atrophy produced by phthalate esters. Arch. Toxicol. Suppl. 1980, 4:452-455.
38. Gray L.E., Ostby J., Sigmon R., Ferrell J., Rehnberg G., Linder R., Cooper R., Goldman J., Laskey J. The development of a protocol to assess reproductive effects of toxicants in the rat. Reprod. Toxicol. 1988, 2:281-287.
39. Guess W.L. Safety evaluation of medical plastics. Clin. Toxicol. 1978, 12:77-95.
40. Gutleb A.C., Meerts I.A.T.M., Bergsma J.H., Schriks M., Murk A.J. T-screen as a tool to identify thyroid hormone receptor active compounds. Environ. Toxicol. Pharmacol. 2005, 19:231-238.
41. Haddow J.E., Palomaki G.E., Allan W.C., Williams J.R., Knight G.J., Gagnon J., O'Heir C.E., Mitchell M.L., Hermos R.J., Waisbren S.E., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 1999, 341:549-555.
42. Harris R.S., Hodge H.C., Maynard E.A., Blanchet H.J. Chronic oral toxicity of 2-ethylhexyl phthalate in rats and dogs. AMA Arch. Ind. Health 1956, 13:259-264.
43. Hauser R., Meeker J.D., Duty S., Silva M.J., Calafat A.M. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology (Cambridge, Mass) 2006, 17:682-691.
44. Hendrickx J.F., Eger E.I., Sonner J.M., Shafer S.L. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesthes. Analg. 2008, 107:494-506.
45. Hill A.B. The environment and disease: association or causation?. Proc. Royal Soc. Med. 1965, 58:295-300. Section on Occupational Medicine Meeting January 14, 1965.
46. Hill R.N., Crisp T.M., Hurley P.M., Rosenthal S.L., Singh D.V. Risk assessment of thyroid follicular cell tumors. Environ. Health Perspect. 1998, 106:447-457.
47. Hines M. Sex steroids and human behavior: prenatal androgen exposure and sex-typical play behavior in children. Annal. N. Y. Acad. Sci. 2003, 1007:272-282.
48. Hofmann P.J., Schomburg L., Kohrle J. Interference of endocrine disrupters with thyroid hormone receptor-dependent transactivation. Toxicol. Sci. 2009, 110:125-137.
49. Howdeshell K.L., Rider C.V., Wilson V.S., Gray L.E. Mechanisms of action of phthalate esters, individually and in combination, to induce abnormal reproductive development in male laboratory rats. Environ. Res. 2008, 108:168-176.
50. Johnson K.J., Hensley J.B., Kelso M.D., Wallace D.G., Gaido K.W. Mapping gene expression changes in the fetal rat testis following acute dibutyl phthalate exposure defines a complex temporal cascade of responding cell types. Biol. Reprod. 2007, 77:978-989.
51. R.S. Judson, K.A. Houck, R.J. Kavlock, T.B. Knudsen, M.T. Martin, H.M. Mortensen, D.M. Reif, D.M. Rotroff, I. Shah, A.M. Richard, D.J. Dix. In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization - The ToxCast Project Evironmental Health Perspectives. Online 14 Dec 2009, http://doi:10.1289/ehp.0901392.
52. Kenyon E.M., Benignus V., Eklund C., Highfill J.W., Oshiro W.M., Samsam T.E., Bushnell P.J. Modeling the toxicokinetics of inhaled toluene in rats: influence of physical activity and feeding status. J. Toxicol. Environ. Health A 2008, 71:249-265.
53. Knudsen T.B., Martin M.T., Kavlock R.J., Judson R.S., Dix D.J., Singh A.V. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB. Reprod. Toxicol. 2009, 28:209-219.
54. Kozumbo W.J., Kroll R., Rubin R.J. Assessment of the mutagenicity of phthalate esters. Environ. Health Perspect. 1982, 45:103-109.
55. Larsson M., Weiss B., Janson S., Sundell J., Bornehag C.G. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8years of age. Neurotoxicology 2009, 30:822-831.
56. Lin H., Ge R.S., Chen G.R., Hu G.X., Dong L., Lian Q.Q., Hardy D.O., Sottas C.M., Li X.K., Hardy M.P. Involvement of testicular growth factors in fetal Leydig cell aggregation after exposure to phthalate in utero. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7218-7222.
57. Main K.M., Mortensen G.K., Kaleva M.M., Boisen K.A., Damgaard I.N., Chellakooty M., Schmidt I.M., Suomi A.M., Virtanen H.E., Petersen D.V., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ. Health Perspect. 2006, 114:270-276.
58. Martin M.T., Judson R.S., Reif D.M., Kavlock R.J., Dix D.J. Profiling chemicals based on chronic toxicity results from the U.S. EPA ToxRef Database. Environ. Health Perspect. 2009, 117:392-399.
59. Martin M.T., Mendez E., Corum D.G., Judson R.S., Kavlock R.J., Rotroff D.M., Dix D.J. Profiling the reproductive toxicity of chemicals from multigeneration studies in the toxicity reference database. Toxicol. Sci. 2009, 110:181-190.
60. Marx J.L. Phthalic acid esters: biological impact uncertain. Science 1972, 178:46-47.
61. Meeker J.D., Calafat A.M., Hauser R. Urinary metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. J. Androl. 2008.
62. Meyer K.H., Hopff H. Narcosis by inert gases under pressure, Hoppe-Seyler's Z. Physiol. Chem. 1923, 126:288-298.
63. Miller M.D., Crofton K.M., Rice D.C., Zoeller R.T. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ. Health Perspect. 2009, 117:1033-1041.
64. Mylchreest E., Cattley R.C., Foster P.M. Male reproductive tract malformations in rats following gestational and lactational exposure to Di(n-butyl) phthalate: an antiandrogenic mechanism?. Toxicol. Sci. 1998, 43:47-60.
65. Narahashi T. Neurophysiological effects of insecticides. Handbook of Pesticide Toxicology 2001, 335-351. Academic Press, San Diego, CA. 2nd Edition. R.I. Krieger (Ed.).
66. NAS, Toxicity Testing: Strategies to Determine Needs and Priorities. National Academy of Sciences, National Research Council, National Academy Press, Washington DC., National Academy Press, Washington, DC, 1984.
67. NRC Toxicity Testing in the 21st Century: a vision and a strategy 2007, The National Academies Press, Washington, D.C.
68. Numann R., Negulescu P.A. High-throughput screening strategies for cardiac ion channels. Trends Cardiovasc. Med. 2001, 11:54-59.
69. Rudolph U., Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat. Rev. Neurosci. 2004, 5:709-720.
70. Russom C.L., Bradbury S.P., Broderius S.J., Hammermeister D.E., Drummond R.A. Predicting modes of toxic action from chemical structure: acute toxicity in the fathead minnow. Environ. Toxicol. Chem. 1997, 16:948-967.
71. Sabb F.W., Burggren A.C., Higier R.G., Fox J., He J., Parker D.S., Poldrack R.A., Chu W., Cannon T.D., Freimer N.B., et al. Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence. Neuroscience 2009, 164:88-107.
72. Schmajuk N.A., Bushnell P.J. A computational model reveals classical conditioning mechanisms underlying visual signal detection in rats. Behav. Process. 2009.
73. Schmajuk N.A., Gray J.A., Lam Y.W. Latent inhibition: a neural network approach. J. Exp. Psychol. Anim. Behav. Process. 1996, 22:321-349.
74. Seed J., Carney E.W., Corley R.A., Crofton K.M., DeSesso J.M., Foster P.M., Kavlock R., Kimmel G., Klaunig J., Meek M.E., et al. Overview: using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit. Rev. Toxicol. 2005, 35:664-672.
75. Shafer T.J., Bushnell P.J., Benignus V.A., Woodward J.J. Perturbation of voltage-sensitive Ca2+ channel function by volatile organic solvents. J. Pharmacol. Exp. Ther. 2005, 315:1109-1118.
76. Shafer S.L., Hendrickx J.F., Flood P., Sonner J., Eger E.I. Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms. Anesthes. Analg. 2008, 107:507-524.
77. Sharpe R.M. "Additional" effects of phthalate mixtures on fetal testosterone production. Toxicol. Sci. 2008, 105:1-4.
78. Sharpe R.M., Fisher J.S., Millar M.M., Jobling S., Sumpter J.P. Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect. 1995, 103:1136-1143.
79. Sharpe R.M., Fisher J.S., Millar M.M., Jobling S., Sumpter J.P. Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect. 1995, 103:1136-1143.
80. Simko J., Horacek J. Carbamazepine and risk of hypothyroidism: a prospective study. Acta Neurol. Scand. 2007, 116:317-321.
81. Soderlund D.M., Clark J.M., Sheets L.P., Mullin L.S., Piccirillo V.J., Sargent D., Stevens J.T., Weiner M.L. Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 2002, 171:3-59.
82. Stahlhut R.W., van Wijngaarden E., Dye T.D., Cook S., Swan S.H. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect. 2007, 115:876-882.
83. Swan S.H. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ. Res. 2008, 108:177-184.
84. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., Mao C.S., Redmon J.B., Ternand C.L., Sullivan S., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 2005, 113:1056-1061.
85. Tepper L.B. Phthalic acid esters - an overview. Environ. Health Perspect. 1973, 3:179-182.
86. Tillar R., Shafer T.J., Woodward J.J. Toluene inhibits voltage-sensitive calcium channels expressed in pheochromocytoma cells. Neurochem. Int. 2002, 41:391-397.
87. Treherne J.M. Exploiting high-throughput ion channel screening technologies in integrated drug discovery. Curr. Pharm. Des. 2006, 12:397-406.
88. Veith G.D., Broderius S.J. Rules for distinguishing toxicants that cause type I and type II narcosis syndromes. Environ. Health Perspect. 1990, 87:207-211.
89. Wolansky M.J., Harrill J.A. Neurobehavioral toxicology of pyrethroid insecticides in adult animals: a critical review. Neurotoxicol. Teratol. 2008, 30:55-78.
90. Yaffe K., Lui L.Y., Zmuda J., Cauley J. Sex hormones and cognitive function in older men. J. Am. Geriatr. Soc. 2002, 50:707-712.
91. Zarcone T.J., Carbonari D.M., Katz A.M., Duncan A.W., Weiss B. High-throughput behavioral quantification of Di(2-ethylhexyl) phthalate (DEHP) exposed rats. Society of Toxicology, March 8. Baltimore, MD 2009.